3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
10
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Glioma
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Brain Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Ependymoma
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Ureteral Neoplasms
1
Thyroid Nodule
1
Interventions
daratumumab
1
Watchful Waiting
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemangioma, Cavernous, Central Nervous System
×
Watchful Waiting
×
1 year
×
Clear all
NCT04467489
2025-08-11
Biomarkers of CASH
University of Chicago
Active not recruiting
1,040 enrolled